Financials

News Ideas Minds Technicals Forecast

SGMT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sagimet Biosciences Inc. - Series A

Total assets of SGMT for Q1 24 is 194.53 M USD, 101.13% more than the previous Q4 23. And total liabilities decreased by 20.23% in Q1 24 to 4.51 M USD.

Q1 '21

Q1 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '21

Q1 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—